Potassium Infusion for Conversion of Atrial Fibrillation/-Flutter

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 143 participants.

Also called NCT01818583

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 143 participants (enrolled count) (from the registry)
Sponsor
Diakonhjemmet Hospital (from the registry)
Registry
  • NCT NCT01818583
Other papers using this trial's data
  • Potassium infusion increases the likelihood of conversion of recent-onset atrial fibrillation-A single-blinded, randomized clinical trial American heart journal, 2020-03 DOI, PubMed 31986288

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Norway (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01818583. Randomized; single masking; primary purpose treatment. Start 2013-03 (actual); primary completion 2017-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Potassium Infusion for Conversion of Atrial Fibrillation/-Flutter
Intervention (Drug)
Potassium chloride
Intervention (Drug)
Glucose 50 MG/ML
Lead sponsor
Diakonhjemmet Hospital (class: other)

Record details

Record id
cardio:ct-nct01818583
Content hash
3f580487a301d63f7a1724a26ed417a4a21aee8f680bb954e6862be92f6b9858